(19)
(11) EP 3 731 837 A2

(12)

(88) Date of publication A3:
12.12.2019

(43) Date of publication:
04.11.2020 Bulletin 2020/45

(21) Application number: 18913688.0

(22) Date of filing: 21.12.2018
(51) International Patent Classification (IPC): 
A61K 31/155(2006.01)
A61K 9/20(2006.01)
A61K 9/48(2006.01)
A61K 31/522(2006.01)
A61P 3/10(2006.01)
(86) International application number:
PCT/TR2018/050857
(87) International publication number:
WO 2019/194773 (10.10.2019 Gazette 2019/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.12.2017 TR 201721505

(71) Applicant: Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
34460 Sariyer/Istanbul (TR)

(72) Inventors:
  • TÜRKYILMAZ, Ali
    34460 Istanbul (TR)
  • PEHLIVAN AKALIN, Nur
    34460 Istanbul (TR)
  • ERGUN DONMEZ, Merve
    34460 Istanbul (TR)

(74) Representative: Sevinç, Erkan 
Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli
34381 Istanbul
34381 Istanbul (TR)

   


(54) THE COMBINATION COMPRISING LINAGLIPTIN AND METFORMIN